Emergence of linezolid resistance in hepatobiliary infections caused by E nterococcus faecium
Open Access
- 3 September 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 22 (2) , 201-208
Abstract
Enterococcal infections are common in liver transplantation and hepatopancreaticobiliary (HPB) surgery. Linezolid is frequently used to treat not only vancomycin-resistant Enterococcus (VRE), but also vancomycin-sensitive Enterococcus (VSE) infections, and resistance can develop. This study evaluated all the Liver Unit patients who developed infections with linezolid-resistant Enterococcus (LRE) in order to elicit the association with prior linezolid usage, to explore possible risk factors for infection, and to better understand the epidemiology of these isolates in this patient group. Between 2010 and 2015, infections with LRE developed in 10 patients (8 following liver transplantation and 2 following HPB surgery) after 22-108 days of treatment. Selected pulsed-field gel electrophoresis demonstrated that 2 out of 10 patients were cocolonized with different strains and indicated that cross-transmission may have occurred. In conclusion, in this group of patients with complex hepatobiliary infections, the optimal antibiotic strategies for the treatment of Enterococcus faecium infections are not clearly defined, and there is a significant risk of emergence of resistance to linezolid in E. faecium after exposure to this agent in patients, especially in the presence of a deep source of infection on a background of hepatic artery insufficiency. Caution is needed when using prolonged courses of linezolid in this setting, and further studies are necessary to determine the optimum treatment. Liver Transpl 22:201-208, 2016. © 2015 AASLD.Keywords
This publication has 33 references indexed in Scilit:
- Systematic Review and Meta-Analysis of Linezolid and Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bloodstream InfectionsAntimicrobial Agents and Chemotherapy, 2013
- Dynamics of ampicillin-resistant Enterococcus faecium clones colonizing hospitalized patients: data from a prospective observational studyBMC Infectious Diseases, 2012
- Outbreak of linezolid-resistant Staphylococcus haemolyticus in an Italian intensive care unitEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Influence of Recombination on Development of Mutational Resistance to Linezolid in Enterococcus faecalis JH2-2Antimicrobial Agents and Chemotherapy, 2009
- Linezolid Resistance in Staphylococcus aureus : Gene Dosage Effect, Stability, Fitness Costs, and Cross-ResistancesAntimicrobial Agents and Chemotherapy, 2008
- Nosocomial Spread of Enterococcus faecium Resistant to Vancomycin and Linezolid in a Tertiary Care Medical CenterJournal of Clinical Microbiology, 2006
- Distribution of Florfenicol Resistance Genes fexA and cfr among Chloramphenicol-Resistant Staphylococcus IsolatesAntimicrobial Agents and Chemotherapy, 2006
- Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case reportJournal of Antimicrobial Chemotherapy, 2005
- Consequences of vancomycin‐resistant Enterococcus in liver transplant recipients: a matched control studyClinical Transplantation, 2005
- Detection of Oxazolidinone-Resistant Enterococcus faecalis and Enterococcus faecium Strains by Real-Time PCR and PCR-Restriction Fragment Length Polymorphism AnalysisJournal of Clinical Microbiology, 2002